Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 3361 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Sutro Biopharma, Inc.

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 02 Apr 2024

Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Generation Bio Co.

Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Evaxion Biotech A/S

Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Onconova Therapeutics, Inc.

Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Roivant Sciences GmbH

Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Nurix Therapeutics, Inc.

TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: TScan Therapeutics, Inc.

Sweetwater Brewing Unveils New 420 Variety Pack

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Tilray Inc.

Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Chemomab Therapeutics Ltd.

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Avantium Technologies B.V. | Avalo Therapeutics, Inc.

Bio-Path Holdings Provides 2024 Clinical and Operational Update

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Bio-Path Holdings, Inc.

Hexiris Welcomes Dr. Paul Harasymowycz to Its Scientific Committee

Read more ››

By: GlobeNewswire - 02 Apr 2024

Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Cara Therapeutics | Carasent ASA

NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: NextCure, Inc

OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at Eyecelerator 2024, a Partner Meeting of the American Society for Cataract and Refractive Surgery

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: OKYO Pharma Limited

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: EyePoint Pharmaceuticals, Inc.

Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Clearside Biomedical, Inc.

Traws Pharma Announces New Employee Inducement Grants

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Onconova Therapeutics, Inc.

Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

Read more ››

By: GlobeNewswire - 02 Apr 2024

Related companies: Arch Biopartners, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑